Advertisement

Metabolomics in Asthma

  • Bruce A. LuxonEmail author
Chapter
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 795)

Abstract

Asthma and airway inflammation are responses to infectious stimuli and the mechanisms of how they are mediated, whether by the innate or adaptive immune response systems, are complex and results in a broad spectrum of possible metabolic products. In principle, a syndrome such as asthma should have a characteristic temporal-spatial metabolic signature indicative of its current state and the constituents that caused it. Generally, the term metabolomics refers to the quantitative analysis of sets of small compounds from biological samples with molecular masses less than 1 kDa so unambiguous identification can be difficult and usually requires sophisticated instrumentation. The practical success of clinical metabolomics will largely hinge on a few key issues such as the ability to capture a readily available biofluid that can be analyzed to identify metabolite biomarkers with the required sensitivity and specificity in a cost-effective manner in a clinical setting. In this chapter, we review the current state of the metabolomics of asthma and airway inflammation with a focus on the different methods and instrumentation being used for the discovery of biomarkers in research and their future translation into the clinic as diagnostic aids for the choice of patient-specific therapies.

Keywords

Nuclear Magnetic Resonance Chronic Obstructive Pulmonary Disease Nuclear Magnetic Resonance Spectrum Chronic Obstructive Pulmonary Disease Patient Airway Inflammation 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. Adamko DJ, Sykes BD, Rowe BH (2012) The metabolomics of asthma: novel diagnostic potential. Chest 141:1295–1302PubMedCrossRefGoogle Scholar
  2. Atzei A, Atzori L, Moretti C et al (2011) Metabolomics in paediatric respiratory diseases and bronchiolitis. The Journal of Maternal-Fetal & Neonatal Medicine 24:59–62Google Scholar
  3. Carraro S, Rezzi S, Reniero F et al (2007) Metabolomics applied to exhaled breath condensate in childhood asthma. American Journal of Respiratory and Critical Care Medicine 175:986–990PubMedCrossRefGoogle Scholar
  4. Cathcart MP, Love S, Hughes KJ (2012) The application of exhaled breath gas and exhaled breath condensate analysis in the investigation of the lower respiratory tract in veterinary medicine: a review. 191:282–291Google Scholar
  5. Chenomx Inc. (2012) http://chenomx.com/. Accessed 3 Nov 2012
  6. Dettmer K, Aronov PA, Hammock BD (2007) Mass spectrometry-based metabolomics. Mass Spectrometry Reviews 26:51–78PubMedCrossRefGoogle Scholar
  7. Dunn WB, Broadhurst D, Begley P et al (2011) Procedures for large-scale metabolic profiling of serum and plasma using gas chromatography and liquid chromatography coupled to mass spectrometry. Nature Protocols 30:1060–1083CrossRefGoogle Scholar
  8. Dutta R, Hines EL, Gardner JW, Boilot P (2002) Bacteria classification using Cyranose 320 electronic nose. BioMed Eng Online 1:4 http://www.biomedical-engineering-online.com/content/1/1/4. Accessed 3 Nov 2012
  9. Fens N, Zwinderman AH, van der Schee MP et al (2009) Exhaled breath profiling enables discrimination of chronic obstructive pulmonary disease and asthma. American Journal of Respiratory and Critical Care Medicine 180:1076–1082PubMedCrossRefGoogle Scholar
  10. Ideo (2012) Cyranose 320 for Cyrano Sciences portable electronic odor detector http://www.ideo.com/work/cyranose-320 Accessed 3 Nov 2012
  11. Izquierdo-García JL, Peces-Barba G, Heili S et al (2011) Is NMR-based metabolomic analysis of exhaled breath condensate accurate? Eur Respir J 37:468–470PubMedCrossRefGoogle Scholar
  12. Junot C, Madalinski G, Tabet JC, Ezan E (2010) Fourier transform mass spectrometry for metabolome analysis. Analyst 135:2203–2219PubMedCrossRefGoogle Scholar
  13. Loukides S, Kontogianni K, Hillas G, Horvath I (2011) Exhaled breath condensate in asthma: from bench to bedside. Current Medicinal Chemistry 18:1432–1443PubMedCrossRefGoogle Scholar
  14. Metz TO, Zhang Q, Page JS et al (2007) The future of liquid chromatography-mass spectrometry (LC-MS) in metabolic profiling and metabolomic studies for biomarker discovery. Biomarkers in Medicine 1:159–185PubMedCrossRefGoogle Scholar
  15. Montuschi P, Paris D, Melck D et al (2012) NMR spectroscopy metabolomic profiling of exhaled breath condensate in patients with stable and unstable cystic fibrosis. Thorax 67:222–228PubMedCrossRefGoogle Scholar
  16. Motta A, Paris D, Melck D et al (2012) Nuclear magnetic resonance-based metabolomics of exhaled breath condensate: methodological aspects. Eur Respir J 39:498–500PubMedCrossRefGoogle Scholar
  17. Saude EJ, Skappak CD, Regush S et al (2011) Metabolomic profiling of asthma: diagnostic utility of urine nuclear magnetic resonance spectroscopy. The Journal of Allergy and Clinical Immunology 127:757–764PubMedCrossRefGoogle Scholar
  18. Metabolomics Society: Metabolomics Software and Servers (2012) http://www.metabolomicssociety.org/software.html. Accessed 3 Nov 2012
  19. Sinha A, Krishnan V, Sethi T et al (2011) Metabolomic signatures in nuclear magnetic resonance spectra of exhaled breath condensate identify asthma. Eur Respir J 39:500–502CrossRefGoogle Scholar
  20. Snowden S, Dahlén SE, Wheelock CE (2012) Application of metabolomics approaches to the study of respiratory diseases. Bioanalysis 4:2265–2290PubMedCrossRefGoogle Scholar
  21. Sofia M, Maniscalco M, de Laurentiis G et al (2011) Exploring airway diseases by NMR-based metabonomics: a review of application to exhaled breath condensate. J Biomed Biotechnol 2011:403260PubMedCrossRefGoogle Scholar
  22. The eNose Company (2012) http://www.enose.nl/. Accessed 3 Nov 2012
  23. Want EJ, Wilson ID, Gika H et al (2010) Global metabolic profiling procedures for urine using UPLC-MS. Nature Protocols 5:1005–1018PubMedCrossRefGoogle Scholar
  24. Zhou B, Xiao JF, Tuli L, Ressom HW (2012) LC-MS-based metabolomics. Molecular BioSystems 8:470–481PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2014

Authors and Affiliations

  1. 1.University of Texas Medical BranchGalvestonUSA

Personalised recommendations